Patent is an amazing tool for enterprises, which allows them to protect their own investments in research and innovation and to acquire additional economical resources through the economic management of its exploitation rights.

Today many companies’ value consists of 90% of intangible assets, mainly composed by industrial property rights. A company with the patent protection is in the position of preventing another company to produce, commercialize and sell a product or a competition, violating its own patent protection.

The patents portfolio is a demonstration of the high quality, specialization and technology capabilities of the company. A patent determines a company enrichment, and also its help to increase the market position.

To date, Kolinpharma has obtained 10 industrial patents in Italy, 6 patents in 12 new European countries beyond Italy, 6 patents in the United States, 1 in Israel and 1 in China, a conquest that is a source of great pride in countries considered a worldwide reference in scientific research and of great importance in the world of nutraceuticals which testifies to the seriousness and accuracy research and confirms the ability of the R&D team to study innovative formulations and develop effective products, based on the most current scientific evidence in the various reference areas.